Showing results (1001-1010 of 31,429) with videos related to

Sort By:
Pageof 3,143
Antimicrobial Agents and Chemotherapy|October 30, 1999
High-performance liquid chromatographic determination of ribavirin in whole blood to assess disposition in erythrocytesM Homma, A L Jayewardene, J Gambertoglio, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faeciumB Bozdogan, R Leclercq
Antimicrobial Agents and Chemotherapy|October 30, 1999
Activities of gemifloxacin (SB 265805, LB20304) compared to those of other oral antimicrobial agents against unusual anaerobesE J Goldstein, D M Citron, C Vreni Merriam, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Specific inhibition of the eubacterial DNA ligase by arylamino compoundsG Ciarrocchi, D G MacPhee, L W Deady, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia sppD J Kenny, P Russell, D Rogers, et al.
Antimicrobial Agents and Chemotherapy|November 5, 1999
Azithromycin activities against Orientia tsutsugamushi strains isolated in cases of scrub typhus in Northern ThailandG Watt, P Kantipong, K Jongsakul, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Compartmental pharmacokinetics and tissue distribution of multilamellar liposomal nystatin in rabbitsA H Groll, D Mickiene, K Werner, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Macrolide resistance genes in Enterococcus sppA Portillo, F Ruiz-Larrea, M Zarazaga, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumoniaE Wang, M Simard, Y Bergeron, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Potent and selective activity of a combination of thymidine and 1843U89, a folate-based thymidylate synthase inhibitor, against Plasmodium falciparumL Jiang, P C Lee, J White, et al.
Pageof 3,143